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Authors’ reply to Vorsters and colleagues
Neha Pathak academic foundation year 2 doctor1, Julie Dodds senior clinical trials manager1, Javier
Zamora senior lecturer in perinatal statistics12, Khalid Khan professor of women’s health and clinical
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1Women’s Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and the London School of Medicine and Dentistry,
London E1 2AB, UK; 2Clinical Biostatistics Unit, Hospital Ramon y Cajal (IRYCIS) and CIBER Epidemiologia y Salud Publica, Madrid, Spain
We thank Vorsters and colleagues for their insightful comments
on our paper.1 2 We agree with Vorsters and colleagues and the
editorialists that further research is needed to evaluate the impact
of urine sampling procedures and testing protocols for the
detection of HPV in urine.3 Indeed, this was a key element of
our discussion. We recommended standardised sampling and
testing protocols to optimise test accuracy and minimise
heterogeneity.
We found that first void urine sampling was associated with
higher test accuracy. Vorsters and colleagues provide an
interesting explanation for this and other potential sources of
heterogeneity, such as timing of urine collection. They also
provide other likely sources of heterogeneity, such as the timing
and volume of first void urine. We thank them for drawing our
attention to the use of collection devices to standardise first void
urine sampling. We agree that these factors could partly explain
the high heterogeneity noted in our review and recommend that
they are taken into account when designing new studies on urine
detection of HPV.
Unfortunately, our systematic review could not explore in depth
all sources of heterogeneity owing to the small number of studies
and the quality of reporting of technical details. Amore powerful
tool such as individual participant data meta-analysis would
provide more insight into the impact of sampling characteristics
on test accuracy.4
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